Results from a large study show that adding two drugs, durvalumab and enfortumab vedotin, before bladder cancer surgery ...

A Pennsylvania man became the first patient to use Inlexzo, a pretzel-looking device that delivers chemo inside the bladder.

The study enrolled 25 patients with high-grade bladder cancer that had come back after earlier BCG treatment. Their median ...

VOLGA was conducted in patients with MIBC ineligible or unwilling to take platinum-based chemotherapy, who received PD-L1 inhibitor Imfinzi (durvalumab) before and after surgery to remove the tumour, ...

Newswise — PHOENIX — A Mayo Clinic-led international phase 3 study found that a new immunotherapy helped many patients with an aggressive form of bladder cancer keep their bladder instead of having it ...

The phase 3 VOLGA trial looks at perioperative durvalumab plus enfortumab vedotin, with and without tremelimumab, for muscle-invasive bladder cancer.

FDA authorization extends perioperative pembrolizumab plus enfortumab vedotin to cystectomy-eligible muscle-invasive bladder cancer, removing the prior restriction to cisplatin-ineligible patients.

ASTRO’s first bladder cancer guideline recommends trimodal therapy as a curative option for selected patients and defines ...

A study of 520 radical cystectomy patients found that perioperative blood transfusion was an independent predictor of venous ...